Compile Data Set for Download or QSAR
maximum 50k data
Found 17 Enz. Inhib. hit(s) with all data for entry = 3277
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Novartis

LigandPNGBDBM30322(Pyrrolo-pyrimidone, 15)
Affinity DataIC50:  42nMpH: 7.5 T: 2°CAssay Description:For MK2 inhibition, reactions contained compound or vehicle control, hsp27 peptide substrate and activated MK2 mix containing ATP. After incubation, ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Novartis

LigandPNGBDBM30323(Pyrrolo-pyrimidone, 16)
Affinity DataIC50:  51nMpH: 7.5 T: 2°CAssay Description:For MK2 inhibition, reactions contained compound or vehicle control, hsp27 peptide substrate and activated MK2 mix containing ATP. After incubation, ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Novartis

LigandPNGBDBM30324(Pyrrolo-pyrimidone, 17)
Affinity DataIC50:  82nMpH: 7.5 T: 2°CAssay Description:For MK2 inhibition, reactions contained compound or vehicle control, hsp27 peptide substrate and activated MK2 mix containing ATP. After incubation, ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Novartis

LigandPNGBDBM30325(Pyrrolo-pyrimidone, 18)
Affinity DataIC50:  150nMpH: 7.5 T: 2°CAssay Description:For MK2 inhibition, reactions contained compound or vehicle control, hsp27 peptide substrate and activated MK2 mix containing ATP. After incubation, ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Novartis

LigandPNGBDBM30315(Pyrrolo-pyrimidone, 8)
Affinity DataIC50:  170nMpH: 7.5 T: 2°CAssay Description:For MK2 inhibition, reactions contained compound or vehicle control, hsp27 peptide substrate and activated MK2 mix containing ATP. After incubation, ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Novartis

LigandPNGBDBM30314(Pyrrolo-pyrimidone, 7)
Affinity DataIC50:  190nMpH: 7.5 T: 2°CAssay Description:For MK2 inhibition, reactions contained compound or vehicle control, hsp27 peptide substrate and activated MK2 mix containing ATP. After incubation, ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Novartis

LigandPNGBDBM30316(Pyrrolo-pyrimidone, 9)
Affinity DataIC50:  200nMpH: 7.5 T: 2°CAssay Description:For MK2 inhibition, reactions contained compound or vehicle control, hsp27 peptide substrate and activated MK2 mix containing ATP. After incubation, ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Novartis

LigandPNGBDBM30317(Pyrrolo-pyrimidone, 10)
Affinity DataIC50:  290nMpH: 7.5 T: 2°CAssay Description:For MK2 inhibition, reactions contained compound or vehicle control, hsp27 peptide substrate and activated MK2 mix containing ATP. After incubation, ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Novartis

LigandPNGBDBM30321(Pyrrolo-pyrimidone, 14)
Affinity DataIC50:  340nMpH: 7.5 T: 2°CAssay Description:For MK2 inhibition, reactions contained compound or vehicle control, hsp27 peptide substrate and activated MK2 mix containing ATP. After incubation, ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Novartis

LigandPNGBDBM30319(Pyrrolo-pyrimidone, 12)
Affinity DataIC50:  350nMpH: 7.5 T: 2°CAssay Description:For MK2 inhibition, reactions contained compound or vehicle control, hsp27 peptide substrate and activated MK2 mix containing ATP. After incubation, ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Novartis

LigandPNGBDBM30311(Pyrrolo-pyrimidone, 4)
Affinity DataIC50:  550nMpH: 7.5 T: 2°CAssay Description:For MK2 inhibition, reactions contained compound or vehicle control, hsp27 peptide substrate and activated MK2 mix containing ATP. After incubation, ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Novartis

LigandPNGBDBM30310(Pyrrolo-pyrimidone, 3)
Affinity DataIC50:  1.23E+3nMpH: 7.5 T: 2°CAssay Description:For MK2 inhibition, reactions contained compound or vehicle control, hsp27 peptide substrate and activated MK2 mix containing ATP. After incubation, ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Novartis

LigandPNGBDBM30320(Pyrrolo-pyrimidone, 13)
Affinity DataIC50:  1.26E+3nMpH: 7.5 T: 2°CAssay Description:For MK2 inhibition, reactions contained compound or vehicle control, hsp27 peptide substrate and activated MK2 mix containing ATP. After incubation, ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Novartis

LigandPNGBDBM30309(Pyrrolo-pyrimidone, 2)
Affinity DataIC50:  1.30E+3nMpH: 7.5 T: 2°CAssay Description:For MK2 inhibition, reactions contained compound or vehicle control, hsp27 peptide substrate and activated MK2 mix containing ATP. After incubation, ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Novartis

LigandPNGBDBM30313(Pyrrolo-pyrimidone, 6)
Affinity DataIC50:  1.45E+3nMpH: 7.5 T: 2°CAssay Description:For MK2 inhibition, reactions contained compound or vehicle control, hsp27 peptide substrate and activated MK2 mix containing ATP. After incubation, ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Novartis

LigandPNGBDBM30318(Pyrrolo-pyrimidone, 11)
Affinity DataIC50:  1.70E+3nMpH: 7.5 T: 2°CAssay Description:For MK2 inhibition, reactions contained compound or vehicle control, hsp27 peptide substrate and activated MK2 mix containing ATP. After incubation, ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Novartis

LigandPNGBDBM30312(Pyrrolo-pyrimidone, 5)
Affinity DataIC50:  5.20E+3nMpH: 7.5 T: 2°CAssay Description:For MK2 inhibition, reactions contained compound or vehicle control, hsp27 peptide substrate and activated MK2 mix containing ATP. After incubation, ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed